v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenues
Costs and expenses:        
Research and development costs 50,696 361,630 202,801 691,402
General and administrative costs 1,750,658 621,627 3,080,302 2,267,890
Total costs and expenses 1,801,354 983,257 3,283,103 2,959,292
Loss from operations (1,801,354) (983,257) (3,283,103) (2,959,292)
Other income (expense):        
Interest income 4,430 1,437 5,236 6,529
Interest expense (457) (1,049) (5,402) (12,389)
Unrealized gain (loss) on digital assets (182,887) (182,887)
Realized gain (loss) on foreign currency transactions (130) (3,161) 530 (3,119)
Net loss (1,980,398) (986,030) (3,465,626) (2,968,271)
Series B Convertible Preferred Stock 8% cumulative dividend (50,367) (50,367)
Net loss attributable to common stockholders $ (2,030,765) $ (986,030) $ (3,515,993) $ (2,968,271)
Net loss per common share basic $ (0.33) $ (0.44) $ (0.92) $ (1.32)
Net loss per common share diluted $ (0.33) $ (0.44) $ (0.92) $ (1.32)
Weighted average common shares outstanding basic 6,171,195 2,249,290 3,801,400 2,249,290
Weighted average common shares outstanding diluted 6,171,195 2,249,290 3,801,400 2,249,290

Source